Showing results (241-250 of 360) with videos related to

Sort By:
Pageof 36
Critical Reviews in Oncology/Hematology|November 9, 2016
First-line antiangiogenics for metastatic renal cell carcinoma: A systematic review and network meta-analysisBenoît Rousseau, Emmanuelle Kempf, Gaelle Desamericq, et al.
The Prostate|July 13, 2017
Ductal adenocarcinoma of the prostate: Clinical and biological profilesArmelle Vinceneux, Franck Bruyère, Olivier Haillot, et al.
The Journal of Urology|July 21, 2009
Urinary collecting system invasion is an independent prognostic factor of organ confined renal cell carcinomaGrégory Verhoest, Raffi Avakian, Karim Bensalah, et al.
International Journal of Radiation Oncology, Biology, Physics|November 14, 2008
External validation of the updated partin tables in a cohort of French and Italian menNaeem Bhojani, Laurent Salomon, Umberto Capitanio, et al.
World Journal of Urology|August 3, 2013
Impact of micropapillary histological variant on survival after radical nephroureterectomy for upper tract urothelial carcinomaAlexandra Masson-Lecomte, Pierre Colin, Gregory Bozzini, et al.
European Urology|July 4, 2008
Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsyJean-Louis Campos-Fernandes, Laurence Bastien, Nathalie Nicolaiew, et al.
Oncotarget|July 11, 2019
Erratum: CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activitiesStéphane Terry, Ihsan Y El-Sayed, Damien Destouches, et al.
Oncotarget|January 19, 2015
CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activitiesStéphane Terry, Ihsan Y El-Sayed, Damien Destouches, et al.
European Urology|August 21, 2014
Preoperative Prostate-specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer: Results from a Multicentric European Prospective StudyNicola Fossati, Nicolò Maria Buffi, Alexander Haese, et al.
World Journal of Urology|April 25, 2012
A switch from GnRH agonist to GnRH antagonist in castration-resistant prostate cancer patients leads to a low response rate on PSAAlexandra Masson-Lecomte, Laurent Guy, Philippe Pedron, et al.
Pageof 36